| 國家衛生研究院 |
2023-04-17 |
HBV DNA integration into telomerase or MLL4 genes and TERT promoter point mutation as three independent signatures in subgrouping HBV-related HCC with distinct features
|
Li, CL;Hsu, CL;Lin, YY;Ho, MC;Chen, CL;Ho, TC;Lin, YF;Tsai, SF;Tzeng, ST;Huang, CF;Wang, YC;Yeh, SH;Chen, PJ |
| 國立成功大學 |
2009-05 |
HBV DNA Level as an Important Determinant of E Antigen Seroconversion of Chronic Hepatitis B during Adefovir Dipivoxil Therapy
|
Tseng, Kuo-Chih; Cheng, Pin-Nan; Wu, I-Chin; Chang, Chin-Kuo; Chou, An-Liang; Liu, Wen-Chun; Chang, Ting-Tsung |
| 臺大學術典藏 |
2020-08-21T07:43:12Z |
HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during Adefovir dipivoxil therapy
|
Wu I.-C.; CHIN-KUO CHANG; Chou A.-L.; Liu W.-C.; Chang T.-T.; Tseng K.-C.; Cheng P.-N. |
| 國立臺灣大學 |
1987 |
HBV DNA Screening in Sera of Maintenance Hemodialysis Patients
|
包家駒; Yang, W. L.; Yang, W. L.; Pao, Chia C.; Yang, W. L.; Yang, W. L. |
| 國立臺灣大學 |
2008 |
Hbv Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles
|
曾岱宗; 高嘉宏; TSENG, TAI-CHUNG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2021-09-04T06:12:36Z |
HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles
|
Tseng T.; JIA-HORNG KAO |
| 國立臺灣大學 |
2012 |
HBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Cheng, Huei-Ru; Jeng, Yung-Ming; Liu, Chen-Hua; Tseng, Tai-Chung; Chen, Chi-Ling; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
HBV genotype is associated with early (week 12) virologic response during TDF or TAF therapy in patients with chronic hepatitis B
|
Acharya, Subrat K.; Lee, Kwan Sik; Kao, Jia-Horng; Flisiak, Robert; Flaherty, John F.; Kim, Kyungpil; Lin, Lanjia; Gaggar, Anuj; Myers, Robert P.; Osipenko, Marina; Pianko, Stephen; Chow, Wan-Cheng; Pan, Calvin Q.; 高嘉宏 |
| 國立臺灣大學 |
2009 |
Hbv Genotypes and Chronicification of Acute Hepatitis B: More Questions Than Answers
|
林志陵; 高嘉宏; LIN, CHIH-LIN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:24Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin C.-L.; JIA-HORNG KAO |
| 國立臺灣大學 |
2005 |
Hbv Genotypes and Outcome of Hbv Infection
|
高嘉宏; 陳定信; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 國立臺灣大學 |
2005 |
HBV genotypes and outcome of HBV infection
|
高嘉宏; 陳定信; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T05:25:25Z |
HBV genotypes and outcome of HBV infection [1] (multiple letters)
|
Kao, J.-H.;Chen, D.-S.;Lok, A.S.F.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:19:06Z |
HBV genotypes and outcome of HBV infection [1] (multiple letters)
|
JIA-HORNG KAO; Chen D.-S.; Lok A.S.F. |
| 國立臺灣大學 |
2005-01 |
HBV genotypes and outcome of HBV infection.
|
Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:00:28Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
Kao, J.-H.;Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:18:58Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng, T.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:01Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng T.-C.; JIA-HORNG KAO |
| 中國醫藥大學 |
2006-04 |
HBV reactivated post chemotherapy
|
蔡金記; 廖光福; 余承儒; 鄭庚申; 彭成元 |
| 中國醫藥大學 |
2006-04-22 |
HBV reactivated post chemotherapy
|
蔡金記(Chin-Chi Tsai); 廖光福(Kuan-Fu Liao); 余承儒(Cheng-Ju Yu); 鄭庚申(Ken-Sheng Cheng); 彭成元(Cheng-Yuan Peng) |
| 國家衛生研究院 |
2009-04-20 |
HBV replication is significantly reduced by IL-6
|
Kuo, TM;Hu, CP;Chen, YL;Hong, MH;Jeng, KS;Liang, CC;Chen, ML;Chang, C |
| 東海大學 |
2009 |
HBV replication is significantly reduced by IL-6
|
Kuo T.M., Hu C., Chen Y.L., Hong M.H., Jeng K.S., Liang C.T., Chen M.L. and Chang C.; 胡承波 |
| 臺大學術典藏 |
2021-07-03T03:33:26Z |
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
|
Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN |
